Caralluma Fimbriata: A Natural Solution for Obesity and Metabolic Syndrome
Caralluma Fimbriata: A Natural Solution for Obesity and Metabolic Syndrome Obesity is one of the most serious public health problems of the 21st century. However, many edible indigenous and wild plants are still overlooked by scientists, nutritionists, and food producers. Among these, Caralluma fimbriata (CF) emerges as a promising medicinal plant, known for its antidiabetic, hypolipidemic, hepatoprotective, and antioxidant properties.
Caralluma fimbriata is known for suppressing appetite due to its high content of pregnane glycosides, which increase endurance and reduce hunger. The plant is also effective in burning fat and blocking fat production by inhibiting the enzyme citrate lyase and the production of malonyl-CoA, promoting the oxidation of stored fatty acids.
Recent Studies on Caralluma Fimbriata
- Study on Overweight Adults: In a study on 83 overweight adults, one group took 1 g/day of CF extract for 16 weeks. The results showed a 2.7 cm decrease in waist circumference and weight loss compared to the placebo group.
- Study on Obese Individuals: Another study found no significant changes in weight, BMI, waist, and hip circumference between the group taking CF extract and the placebo group.
- Study on Obese Rats: In rats, Caralluma fimbriata extract showed a significant reduction in body weight and lipid profile.
- Study with Dietary Restriction and Exercise: In another study on 33 overweight subjects, CF extract (500 mg twice a day) led to a significant decrease in BMI, body weight, hip circumference, total fat, and systolic blood pressure.
Caralluma fimbriata represents a natural, safe, and effective appetite suppressant for weight loss and the reduction of blood glucose and lipids. Despite the promising results, research on CF is still in its early stages, and further studies are needed to fully explore its therapeutic potential. Particular attention should be paid to pregnane glycosides, the key phytochemicals of this plant.
If your company is looking to create or manufacture a product useful for obesity and metabolic syndrome
